Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 56151-56200 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT04400604
Study of Alcohol-related Liver Disease in Europe
N/A
Recruiting
7,500 participants
Started: Mar 3, 2021 · Completed: Mar 31, 2032
1 condition
1 sponsor
1 location
NCT03938987
Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
PHASE1/PHASE2
Recruiting
63 participants
Started: Mar 3, 2021 · Completed: Dec 31, 2027
3 conditions
3 sponsors
6 locations
NCT04804007
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
PHASE2
Recruiting
64 participants
Started: Mar 3, 2021 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT04803929
Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
EARLY_PHASE1
Recruiting
25 participants
Started: Mar 3, 2021 · Completed: Mar 1, 2026
2 conditions
2 sponsors
1 location
NCT04658251
Study of New Mutations in Cone Disorders
N/A
Recruiting
20 participants
Started: Mar 3, 2021 · Completed: Mar 31, 2026
4 conditions
1 sponsor
1 location
NCT04678648
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PHASE1
Recruiting
134 participants
Started: Mar 3, 2021 · Completed: Jan 30, 2027
6 conditions
1 sponsor
3 locations
NCT04784364
Biologics and Clinical Immunology Cohort At Sinai
N/A
Recruiting
800 participants
Started: Mar 3, 2021 · Completed: Nov 30, 2028
3 conditions
1 sponsor
1 location
NCT04778956
Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma
PHASE3
Recruiting
218 participants
Started: Mar 3, 2021 · Completed: Mar 3, 2033
3 conditions
6 sponsors
7 locations
NCT04709796
The Use of High Concentration Hyaluronic Acid (HA) Transfer Medium in Repeated Implantation Failure (RIF) Patients
NA
Recruiting
178 participants
Started: Mar 3, 2021 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
NCT05257746
Perioperative and Postoperative Evaluation of Rectal and Urogenital Function in Patients Undergoing Rectal Resection
N/A
Recruiting
500 participants
Started: Mar 3, 2021 · Completed: Jun 30, 2030
1 condition
1 sponsor
1 location
NCT04254861
Autologous Platelet Concentrate (APC) in Intrabony Defects
NA
Recruiting
74 participants
Started: Mar 2, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04692597
Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis.
NA
Recruiting
126 participants
Started: Mar 2, 2021 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT04747912
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
PHASE2
Recruiting
25 participants
Started: Mar 2, 2021 · Completed: Mar 1, 2027
3 conditions
1 sponsor
1 location
NCT04719156
Fluorescent Intra-operative Tumor Margin Examination
PHASE2
Recruiting
110 participants
Started: Mar 2, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04040608
Influence of Screen Sizes on Responses to Visual Analog Scales of Stress
N/A
Recruiting
200 participants
Started: Mar 2, 2021 · Completed: Mar 31, 2026
1 condition
3 sponsors
1 location
NCT04978168
Opioid Treatment and Peer Recovery Support
NA
Recruiting
450 participants
Started: Mar 2, 2021 · Completed: Apr 30, 2026
1 condition
8 sponsors
3 locations
NCT04836507
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
PHASE1/PHASE2
Recruiting
91 participants
Started: Mar 2, 2021 · Completed: Feb 29, 2028
6 conditions
1 sponsor
1 location
NCT04457596
T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
PHASE3
Recruiting
1,031 participants
Started: Mar 2, 2021 · Completed: May 31, 2035
22 conditions
3 sponsors
1176 locations
NCT04699201
Trocar Site Incisional Hernia Prevention
NA
Recruiting
94 participants
Started: Mar 2, 2021 · Completed: Feb 28, 2025
1 condition
3 sponsors
2 locations
NCT04766866
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NA
Recruiting
9,132 participants
Started: Mar 2, 2021 · Completed: Dec 31, 2026
5 conditions
2 sponsors
21 locations
NCT04802395
Real World Evidence Clinical Utility Study of KidneyIntelX
N/A
Recruiting
10,000 participants
Started: Mar 2, 2021 · Completed: Dec 1, 2026
2 conditions
2 sponsors
1 location
NCT04269902
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
PHASE3
Recruiting
247 participants
Started: Mar 2, 2021 · Completed: Oct 1, 2028
2 conditions
1 sponsor
621 locations
NCT04689152
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
PHASE3
Recruiting
200 participants
Started: Mar 2, 2021 · Completed: Jan 2, 2028
1 condition
1 sponsor
11 locations
NCT04658693
Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
NA
Recruiting
15 participants
Started: Mar 2, 2021 · Completed: Sep 2, 2027
2 conditions
1 sponsor
1 location
NCT05153824
Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
N/A
Recruiting
200 participants
Started: Mar 2, 2021 · Completed: Sep 2, 2027
1 condition
1 sponsor
2 locations
NCT05237570
Minimally Invasive Sinus Lift Through the Interradicular Septum
NA
Recruiting
20 participants
Started: Mar 2, 2021 · Completed: Dec 1, 2025
4 conditions
1 sponsor
1 location
NCT04754672
Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome
NA
Recruiting
228 participants
Started: Mar 2, 2021 · Completed: Dec 31, 2026
4 conditions
14 sponsors
13 locations
NCT04506008
Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas
PHASE2
Recruiting
40 participants
Started: Mar 2, 2021 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT04594642
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
PHASE1
Recruiting
317 participants
Started: Mar 2, 2021 · Completed: Apr 19, 2028
4 conditions
1 sponsor
27 locations
NCT04295486
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
PHASE2
Recruiting
5,478 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT04897490
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
N/A
Recruiting
50 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
6 locations
NCT04830267
The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC
PHASE2
Recruiting
39 participants
Started: Mar 1, 2021 · Completed: Aug 1, 2026
1 condition
1 sponsor
3 locations
NCT05213000
Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
NA
Recruiting
80 participants
Started: Mar 1, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT04535661
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
N/A
Recruiting
536 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04664270
Developing and Implementing E-psychotherapy Program for Mental Health Challenges in Oncology and Palliative Care
NA
Recruiting
60 participants
Started: Mar 1, 2021 · Completed: Sep 30, 2025
5 conditions
2 sponsors
1 location
NCT04880356
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
N/A
Recruiting
100 participants
Started: Mar 1, 2021 · Completed: Mar 31, 2031
6 conditions
1 sponsor
1 location
NCT04995068
Score Predicting Lesion Development on CT Following Mild TBI
N/A
Recruiting
20,000 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
2 conditions
6 sponsors
1 location
NCT04839887
Factors Affecting the Quality of Life After Ischemic Stroke in Young Adults
N/A
Recruiting
520 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04639791
To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong
N/A
Recruiting
500 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04652830
Naprapathy Training for Postpartum DRAM Prevention
NA
Recruiting
70 participants
Started: Mar 1, 2021 · Completed: Oct 31, 2026
1 condition
2 sponsors
1 location
NCT05334732
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
NA
Recruiting
150 participants
Started: Mar 1, 2021 · Completed: Feb 28, 2026
1 condition
2 sponsors
2 locations
NCT04993014
Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer
PHASE2
Recruiting
80 participants
Started: Mar 1, 2021 · Completed: Apr 30, 2028
3 conditions
1 sponsor
1 location
NCT04175535
The Comparative Study of Full-Endoscopic Cervical Posterior Discectomy and Anterior Cervical Decompression and Fusion
NA
Recruiting
308 participants
Started: Mar 1, 2021 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT04650321
Home Based Infusions for Ocrelizumab
PHASE4
Recruiting
110 participants
Started: Mar 1, 2021 · Completed: Aug 31, 2021
1 condition
2 sponsors
1 location
NCT05635032
Fibrosing ILD Biomarkers That Rule Acceleration
N/A
Recruiting
150 participants
Started: Mar 1, 2021 · Completed: Mar 31, 2026
2 conditions
4 sponsors
1 location
NCT04745221
Efficacy and Safety of Auto-FMT in Preventing aGVHD
NA
Recruiting
100 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT05286736
Neuroplasticity in Parkinson's Disease
N/A
Recruiting
50 participants
Started: Mar 1, 2021 · Completed: Nov 9, 2028
2 conditions
1 sponsor
1 location
NCT05479409
Neoadjuvant Radiation in Locally Advanced Breast Cancer
PHASE2
Recruiting
50 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04719221
Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome
PHASE4
Recruiting
60 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04755569
Optimizer System With ODOCOR II CCM™ Leads
N/A
Recruiting
200 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
40 locations
Previous
1
More pages
1121
1122
1123
1124
1125
1126
1127
More pages
1333
Next